What is CGNSF stock price today?

CGNSF (Cognetivity Neurosciences Ltd) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CGNSF stock going up or down today?

CGNSF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CGNSF stock now?

The decision to buy CGNSF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CGNSF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CGNSF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CGNSF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CGNSF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CGNSF's P/E ratio?

P/E ratio data for CGNSF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CGNSF's market cap?

CGNSF (Cognetivity Neurosciences Ltd) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CGNSF's price to book ratio?

CGNSF trades at a price-to-book (P/B) ratio of 189.01, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does CGNSF pay dividends?

CGNSF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CGNSF's dividend yield?

CGNSF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CGNSF stock a good long-term investment?

CGNSF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CGNSF's revenue growth rate?

Revenue growth data for CGNSF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CGNSF are available on our dashboard with complete income statement analysis.

What are the risks of investing in CGNSF?

Key risks for CGNSF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CGNSF compare to its competitors?

Compare CGNSF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CGNSF's performance and positioning.

What is CGNSF's stock price target for 2026?

Our AI model provides price targets for CGNSF based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CGNSF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CGNSF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CGNSF's next earnings report?

CGNSF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CGNSF - Cognetivity Neurosciences Ltd

NYSE * Healthcare * Health Information Services

$0.00

+$0.00 (+0.00%)

About Cognetivity Neurosciences Ltd

Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

CGNSF Key Statistics

Market Cap

$0.01M

P/B Ratio

189.01

EPS

$-0.06

How CGNSF Compares to Peers

CGNSF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CGNSF(This stock)	$8.96K	N/A	0%	0.0%	-
UNHUnitedhealth Group	$294.66B	24.5	0%	0.0%	vs UNH
JNJJohnson &	$564.35B	21.2	0%	0.2%	vs JNJ
LLYEli Lilly	$829.71B	40.4	0%	0.3%	vs LLY
PFEPfizer Inc	$156.77B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$368.57B	87.6	0%	0.1%	vs ABBV

Cognetivity Neurosciences Ltd Company Information

Headquarters: 1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9, undefined
Website: cognetivity.com
Sector: Healthcare
Industry: Health Information Services

Data Updated: April 19, 2026 at 6:49 PM EDT

Ready to invest in CGNSF?

Commission-free trading available. Affiliate links.

Upcoming Events for CGNSF

Dashboard

Enter a ticker to analyze